Cover Image

Prevalence of risk factors in diabetic patients candidate for cabg surgery

Fatemeh Javaherforoosh Zadeh*, Simin Azemati


The prevalence of diabetes is increasing worldwide and the Middle East, diabetic patient have many risk factor and comorbidity that can high risk for any surgery especially for cardiac surgery. The aim of this study is determining the prevalence of comorbidities in diabetic patients scheduled for CABG. This is a retrospective study. We referred to archive of Faghihi hospitals, gathered files of the Diabetic patients who underwent CABG in 2013 and extracted required data from them. Data gathering instrument was researcher-constructed questionnaire including patients’ demographic information. In this study, we have examined 75 diabetic patients scheduled for CABG, 30 of them male and there were 45 female. The most and least common comorbidities were hypertension (62.6%) and renal failure (2.6%). But in male patients, the most and least common risk factors were smoking (63.6%) and renal failure (3.3%) respectively. Also in female patients, hypertension (80%) and renal failure (2.2%) were the most and least common risk factors. According to high prevalence of hypertension in diabetic patients scheduled for CABG, it is better to control diet in these patients to decrease morbidity and mortality rates. More studies are suggested to evaluate more variables


Diabetic Patients; CABG; Cardiac Surgery

Full Text:



Adams, Gary G., et al., The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines. Food Research International 44.4 (2011): 862-867.‏

Shaw, Jonathan E, Richard A Sicree and Paul Z. Zimmet. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice 87.1 (2010): 4-14.‏

Schramm, Tina Ken, et al., Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. European heart journal (2011): ehr077.‏

Harati H, Hadaegh F, Saadat N, Azizi F. Population based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009; 9: 186.

Stirban AO, Tschoepe D. Cardiovascular complications in diabetes: targets and interventions. Diabetes Care 2008; 31 Suppl 2: S215-21.

Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-32.

Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, et al., Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003; 26: 16-23.

Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart 2009; 95: 454-60.

Kalaitzidis R, Bakris G. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers. Diabetes Obes Metab 2009; 11: 757- 69.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al., (Diabetes control and complications trial/epidemiology of diabetes interventions and complications study research group). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Eng J Med 2005; 353: 2643-53.

Yokoyama H, Oishi M, Kawai K, Sone H. Reduced GFR and micro-albuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Diabet Med 2008; 25: 1426- 32.

Klausen KP, Parving HH, Scharling H, Jensen JS. Micro-albuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2009; 71: 40-5.

Grundy SM. Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient? Am J Med 2007; 120 Suppl 1: S3-8.

Jamieson Meredith. Factors, Influencing Health Related Quality of life in Cardiac Rehabilitation Patient Progressing. Cardiovascular Nursing 2002, 17(3): 124-131.

Gupta S, Saxena SK, Lalchandani A, Chandra R, Gupta AC, Mishra MP. Significance of Platelet Volume Indices in Patients of Coronary Artery Diseases (Cad) and Acute Myocardial Infarction (MI): A New Predictor For Ihd. Indian Journal of Cardiology ISSN. 2012;972:1622.

Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic conceptsThe epidemic of cardiovascular disease in the developing world: global implications. European heart journal. 2010;31(6):642-8.

Nazeer M, Naveed T, Ullah A. A Case–Control Study of Risk Factors for Coronary Artery Disease in Pakistani Females. Annals of King Edward Medical University. 2011;16, 3.

Hatmi Z, Tahvildari S, Motlag AG, Kashani AS. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovascular Disorders. 2007;7(1):32

World Health Organization. Cardiovascular disease. Geneva, Switzerland: WHO; 2008.

Moore S. CABG Discharge information addressing women’s recovery. Clinical Nursing Research. 2000; 5(1): 97-99

Eastwood, Jo-Ann and Lynn V. Doering. Gender differences in coronary artery disease. Journal of Cardiovascular Nursing 20, no. 5 (2005): 340-351.

Forouzannia, Seyed Khalil, et al., Comparing Effects of Continuous Insulin Infusion with or without Subcutaneous Glargine Insulin on Glycemic Control in Diabetic Patients Undergoing Coronary Artery Bypass Graft (CABG). Iranian Journal of Diabetes and Obesity 1.1 (2009): 5-10.‏

Gandhi, Gunjan Y, et al., Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery A Randomized Trial. Annals of internal medicine 146.4 (2007): 233-243.‏

Bangash, Sohail Khan, Saad Bader Zakai, and Iqbal Hussain Pathan. Effects of Strict Glycemic Control on Morbidity & Mortality of Diabetic Patients Post-Cabg. Pjc 24 (2013): 28-32.‏

Furnary, Anthony P, et al., Continuous Insulin Infusions Reduce Mortality in Diabetic CABG patients. Providence (2002). 2-47‏.



  • There are currently no refbacks.

Copyright (c) 2015 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.